Zentalis Pharmaceuticals, Inc. (ZNTL)
1.695
+0.02
(+0.89%)
USD |
NASDAQ |
Nov 13, 16:00
1.695
0.00 (0.00%)
After-Hours: 19:59
Zentalis Pharmaceuticals Market Cap : 166.55M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 165.08M |
| November 11, 2026 | 185.71M |
| November 10, 2026 | 176.87M |
| November 09, 2026 | 170.97M |
| November 06, 2026 | 169.01M |
| November 05, 2026 | 168.03M |
| November 04, 2026 | 126.14M |
| November 03, 2026 | 127.57M |
| November 02, 2026 | 132.59M |
| October 30, 2026 | 140.47M |
| October 29, 2026 | 142.62M |
| October 28, 2026 | 147.64M |
| October 27, 2026 | 141.90M |
| October 26, 2026 | 148.35M |
| October 23, 2026 | 158.39M |
| October 22, 2026 | 172.72M |
| October 21, 2026 | 169.14M |
| October 20, 2026 | 171.29M |
| October 19, 2026 | 164.84M |
| October 16, 2026 | 152.65M |
| October 15, 2026 | 160.54M |
| October 14, 2026 | 166.27M |
| October 13, 2026 | 172.00M |
| October 12, 2026 | 180.60M |
| October 09, 2026 | 189.21M |
| Date | Value |
|---|---|
| October 08, 2026 | 179.89M |
| October 07, 2026 | 182.75M |
| October 06, 2026 | 191.36M |
| October 05, 2026 | 199.24M |
| October 02, 2026 | 180.60M |
| October 01, 2026 | 186.70M |
| September 30, 2026 | 198.52M |
| September 29, 2026 | 194.58M |
| September 28, 2026 | 186.34M |
| September 25, 2026 | 193.51M |
| September 24, 2026 | 197.09M |
| September 23, 2026 | 205.69M |
| September 22, 2026 | 220.74M |
| September 21, 2026 | 217.16M |
| September 18, 2026 | 222.89M |
| September 17, 2026 | 220.74M |
| September 16, 2026 | 222.17M |
| September 15, 2026 | 224.32M |
| September 14, 2026 | 250.84M |
| September 11, 2026 | 251.56M |
| September 10, 2026 | 257.29M |
| September 09, 2026 | 272.34M |
| September 08, 2026 | 288.82M |
| September 04, 2026 | 285.96M |
| September 03, 2026 | 294.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ARS Pharmaceuticals, Inc. | 391.47M |
| ACADIA Pharmaceuticals, Inc. | 3.238B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 178.74M |
| Savara, Inc. | 952.66M |
Market Cap Related Metrics
| Price to Book Value | 0.8129 |
| Price | 1.695 |
| Earnings Yield | -113.7% |